Evidence map›Paper›PMID 32990320›Full record

ReviewHistology and histopathology2021

Rab GTPases in the differential processing of phagocytosed pathogens versus efferocytosed apoptotic cells.

Nima Taefehshokr, Charles Yin, Bryan Heit

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Histology and histopathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Analysis of theGenes · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nima TaefehshokrDepartment of Microbiology and Immunology, Center for Human Immunology, The University of Western Ontario, London, Ontario, Canada.
Charles YinDepartment of Microbiology and Immunology, Center for Human Immunology, The University of Western Ontario, London, Ontario, Canada.
Bryan HeitDepartment of Microbiology and Immunology, Center for Human Immunology, The University of Western Ontario, London, Ontario, Canada. bheit@uwo.ca.
Western University · CARobarts Clinical Trials · CA

Funding

Canadian Institute for Health Research Operating Grant 406738
6 · The paper itself

Abstract

Phagocytosis is an important feature of innate immunity in which invading microorganisms are engulfed, killed and degraded - and in some immune cells, their antigens presented to adaptive immune system. A closely related process, efferocytosis, removes apoptotic cells, and is essential for the maintenance of homeostasis. Both phagocytosis and efferocytosis are tightly regulated processes that involve target recognition and uptake through specific receptors, followed by endolysosomal trafficking and processing of the internalized target. Central to the uptake and trafficking of these targets are the Rab family of small GTPases, which coordinate the engulfment and trafficking of both phagocytosed and efferocytosed materials through the endolysosomal system. Because of this regulatory function, Rab GTPases are often targeted by pathogens to escape phagocytosis. In this review, we will discuss the shared and differential roles of Rab GTPases in phagocytosis and efferocytosis.

Indexed as

ApoptosisPhagocytosisAnimalsAntigensAutoimmunityBiological TransportEndosomesHistocompatibility Antigens Class IIHomeostasisHumansLysosomesMacrophagesPhagosomesProtein Transportrab GTP-Binding ProteinsAntigensHistocompatibility Antigens Class IIrab GTP-Binding Proteins

Identifiers

PMID32990320
OpenAlexW3089722209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.